abrdn Life Sciences Investors

NYSE:HQLFinancial Services

$17.03+1.49%At closeAt close · Tue 20 Oct · ≈ AED 62.54 · Market cap —

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	86.7%	86.5%	82.6%	46.4%	100.0%	100.0%	—	—
Operating margin	314.9%	143.3%	−328.3%	−13.3%	98.4%	99.1%	99.1%	+0.0 pts
Net margin	314.9%	143.3%	−328.3%	56.8%	98.4%	99.1%	99.1%	+0.0 pts
EBITDA margin	315.0%	152.5%	−318.9%	126.8%	100.6%	99.1%	—	—
Return on equity	25.4%	12.3%	−26.3%	5.6%	18.6%	16.7%	16.7%	+0.0 pts
Return on assets	25.4%	12.1%	−25.2%	5.6%	18.5%	16.6%	16.6%	+0.0 pts
Return on capital employed	25.4%	12.3%	−25.5%	−1.3%	18.6%	16.6%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—
Debt / assets	0.0%	0.3%	2.7%	0.0%	0.0%	0.0%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	0.1×	0.0×	0.1×	—	0.3×	1.7×	1.7×	+0.0%
Quick ratio	0.1×	0.0×	0.1×	—	0.3×	1.7×	—	—
Cash ratio	−8.5×	0.0×	0.0×	—	0.0×	0.1×	0.1×	+0.0%
Asset turnover	0.1×	0.1×	0.1×	0.1×	0.2×	0.2×	—	—
Receivables turnover	528.7×	299.5×	51.1×	7.8×	375.1×	75.9×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	—	37.0%	—	—

Margins, returns, leverage and liquidityUpdated 30 Sep 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.